Skip to main content
HeartCited

Folate (Vitamin B9) 用于 Coronary Artery Disease (CAD)

C

CSPPT showed stroke benefit but not MI benefit. HOPE-2 was negative for cardiovascular events despite homocysteine reduction. Research suggests benefit may be limited to populations without folic acid fortification.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dfolate\u0026condition\u003Dcoronary\u002Dartery\u002Ddisease'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

结论

CSPPT showed stroke benefit but not MI benefit. HOPE-2 was negative for cardiovascular events despite homocysteine reduction. Research suggests benefit may be limited to populations without folic acid fortification.

Key Statistics

10

研究数量

40000

受试者

Mixed

C

等级

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

general:
400 mcg DFE/day
homocysteinereduction:
400-800 mcg/day folic acid (with B12 and B6)

上限: 1,000 mcg/day folic acid from supplements

最佳服用时间: With or without food; consistent daily timing preferred

Safety & Side Effects

已报告的副作用

  • Generally very well-tolerated
  • May mask vitamin B12 deficiency at high doses
  • Rare: mild gastrointestinal discomfort

已知相互作用

  • Methotrexate (folate may reduce efficacy)
  • Antiepileptic drugs (phenytoin, carbamazepine — mutual interference)
  • Vitamin B12 (co-supplementation recommended for homocysteine reduction)

可耐受最高摄入量: 1,000 mcg/day folic acid from supplements

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does Folate (Vitamin B9) help with Coronary Artery Disease (CAD)?
Based on 10 studies with 40,000 participants, there is limited but promising evidence that Folate (Vitamin B9) may support Coronary Artery Disease (CAD) management. Our evidence grade is C (Some Evidence).
How much Folate (Vitamin B9) should I take for Coronary Artery Disease (CAD)?
Studies have used various dosages. A commonly studied range is 400 mcg DFE/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Folate (Vitamin B9)?
Reported side effects may include Generally very well-tolerated, May mask vitamin B12 deficiency at high doses, Rare: mild gastrointestinal discomfort. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Folate (Vitamin B9) and Coronary Artery Disease (CAD)?
We rate the evidence as Grade C (Some Evidence). This rating is based on 10 peer-reviewed studies with 40,000 total participants. The overall direction of effect is mixed.

Related Evidence

其他成分用于 Coronary Artery Disease (CAD)

Folate (Vitamin B9) 用于其他健康状况

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。